You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Zanubrutinib for treating relapsed or refractory mantle cell lymphoma

  • Technology appraisal guidance
  • Reference number: TA1081
  • Published:  10 July 2025
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Resource impact
  2. Guidance into practice

Tools and resources

Tools and resources to help you put the guidance into practice.

Resource impact

  • Resource impact template (Excel 2.3 MB)

    Published:
    10 July 2025
  • Resource impact summary report

Guidance into practice

  • About the Into practice guide

  • Practical steps to improving the quality of care and services using NICE guidance

Back to top